Regeneron (REGN) Misses Q4 GAAP EPS Views on R&D, Pipeline Expansion, but EYLEA Shaping-Up Well - Roth Capital
Go back to Regeneron (REGN) Misses Q4 GAAP EPS Views on R&D, Pipeline Expansion, but EYLEA Shaping-Up Well - Roth Capital| Regeneron (NASDAQ: REGN) | Delayed: 649.81 -4.46 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $654.27 | 52 Week High | $592.36 | |||
| Open | $657.96 | 52 Week Low | $325.35 | |||
| Day High | $657.96 | P/E | 170.55 | |||
| Day Low | $637.72 | EPS | $3.81 | |||
| Volume | 714,337 | |||||

